Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Neurotoxicity Research|September 10, 2020
Peripheral Pain Modulation of Chrysaora pacifica Jellyfish Venom Requires Both Ca2+ Influx and TRPA1 Channel Activation in RatsHye-Ji Kim, Jin-Woo Noh, Khulan Amarsanaa, et al.
Journal of Oncology|January 25, 2020
Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast CancerYoung-Joon Kang, Han-Byoel Lee, Yun Gyoung Kim, et al.
Journal of Breast Cancer|January 3, 2022
Impact of the COVID-19 Pandemic on the Diagnosis and Surgery of Breast Cancer: A Multi-Institutional StudyYoung-Joon Kang, Jong Min Baek, Yong-Seok Kim, et al.
BMC Cancer|June 20, 2023
A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial)Young-Joon Kang, Chang Ik Yoon, Yun-Jung Yang, et al.
Plos One|March 22, 2017
The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbiditiesJaihong Han, Han-Byoel Lee, Eun-Shin Lee, et al.
The American Journal of Emergency Medicine|December 30, 2011
Blood ammonia is a predictive biomarker of neurologic outcome in cardiac arrest patients treated with therapeutic hypothermiaYoung Mo Cho, Yong Su Lim, Hyuk Jun Yang, et al.
Korean Journal of Clinical Oncology|May 8, 2026
Risk stratification for malignant upgrade in breast atypical hyperplasia: a Korean multi-institutional analysis from academic hospitalsHyobin Kim, Jung Ho Park, Min Kyoon Kim, et al.
Scientific Reports|July 7, 2023
Predictive biological factors for late survival in patients with HER2-positive breast cancerYoung-Joon Kang, Se Jeong Oh, Soo Youn Bae, et al.
Journal of Breast Cancer|July 9, 2015
Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional RecurrenceSoojin Park, Wonshik Han, Jongjin Kim, et al.
Breast Cancer Research and Treatment|January 3, 2021
Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean Breast Cancer SocietyYoung-Joon Kang, Se Jeong Oh, Hoon Choi, et al.
Pageof 4